Clinical trial

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.

NCT01533935

Study summary

ClinicalTrials.gov

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Tiotropium + Olodaterol Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention tiotropium + Olodaterol Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Tiotropium Normalized identity: tiotropium View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Olodaterol Normalized identity: olodaterol View linked drug · Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Respimat Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-02-01

PhasePHASE3

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

PlaceboDRUG

Tiotropium + OlodaterolDRUG

tiotropium + OlodaterolDRUG

TiotropiumDRUG · verified · RxNorm: tiotropium

OlodaterolDRUG · verified · RxNorm: olodaterol

RespimatDEVICE

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

DallasTexas, United States1 BaltimoreMaryland, United States1 TorontoOntario, Canada1 SeattleWashington, United States1 MontrealQuebec, Canada1 PhoenixArizona, United States1 RochesterMinnesota, United States1 MoscowRussia1 CharlotteNorth Carolina, United States1 Saint PetersburgRussia1 HamburgGermany1 VancouverBritish Columbia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01533935 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.